Medindia

X

Dr Reddy's Laboratories Introduces Generic Cancer Drug in the US Market

by Savitha C Muppala on  July 13, 2013 at 8:43 AM Drug News   - G J E 4
Pharmaceutical company, Dr Reddy's Laboratories has announced the launch of its generic Decitabine injection employed to treat cancer.
 Dr Reddy's Laboratories Introduces Generic Cancer Drug in the US Market
Dr Reddy's Laboratories Introduces Generic Cancer Drug in the US Market
Advertisement

It has introduced this drug in the US market after USFDA approved the use of the drug. The injection in the strength of 50 mg has been launched in the US market and will be available as a single vial.

Advertisement
"The Dacogen brand has US sales of approximately USD 260 million MAT (moving annual total) for the most recent twelve months ending in July 2013 according to IMS Health," Dr Reddy's said.

Dacogen is employed to treat myelodysplastic syndromes and for acute myeloid leukemia.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All